Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25002-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- RPL22 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated RPL22 antibody (Cat. #25002-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease.
Early Scanning of Nascent Polypeptides inside the Ribosomal Tunnel by NAC.
Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.
The molecular landscape of synchronous colorectal cancer reveals genetic heterogeneity.
Rimal S, Li Y, Vartak R, Geng J, Tantray I, Li S, Huh S, Vogel H, Glabe C, Grinberg LT, Spina S, Seeley WW, Guo S, Lu B
Acta neuropathologica communications 2021 Oct 18;9(1):169
Acta neuropathologica communications 2021 Oct 18;9(1):169
Early Scanning of Nascent Polypeptides inside the Ribosomal Tunnel by NAC.
Gamerdinger M, Kobayashi K, Wallisch A, Kreft SG, Sailer C, Schlömer R, Sachs N, Jomaa A, Stengel F, Ban N, Deuerling E
Molecular cell 2019 Sep 5;75(5):996-1006.e8
Molecular cell 2019 Sep 5;75(5):996-1006.e8
Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.
Del Toro N, Fernandez-Ruiz A, Mignacca L, Kalegari P, Rowell MC, Igelmann S, Saint-Germain E, Benfdil M, Lopes-Paciencia S, Brakier-Gingras L, Bourdeau V, Ferbeyre G, Lessard F
Cell cycle (Georgetown, Tex.) 2019 Mar - Apr;18(6-7):759-770
Cell cycle (Georgetown, Tex.) 2019 Mar - Apr;18(6-7):759-770
The molecular landscape of synchronous colorectal cancer reveals genetic heterogeneity.
Wang X, Fang H, Cheng Y, Li L, Sun X, Fu T, Huang P, Zhang A, Feng Z, Li C, Huang X, Li G, Du P, Yang H, Fang X, Li F, Gao Q, Liu B
Carcinogenesis 2018 May 3;39(5):708-718
Carcinogenesis 2018 May 3;39(5):708-718
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- A431 cells were subjected to SDS PAGE followed by western blot with 25002-1-AP( RPL22 Antibody) at dilution of 1:600
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The RPL22 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human RPL22. This antibody recognizes human antigen. The RPL22 antibody has been validated for the following applications: ELISA, WB, IF analysis.
